Lingjun Dong

Statistics

Publications

Citations

191

H-Index

Active since

2019

Affiliations

Second Affiliated Hospital of Zhejiang University(Current)

Shaoxing People's Hospital

Zhejiang University

Lingjun Dong is an author at Second Affiliated Hospital of Zhejiang University specializing in inflammation, pulmonary fibrosis progression, and pulmonary inflammation.

ORCID

Publications per year

2019–2024

Publications

Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice

Ya-Ling Chen, Tong Wang, Fuxiang Liang et al. · Theranostics · 2024 · 52 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Necrostatin-1 Alleviates Lung Ischemia-Reperfusion Injury via Inhibiting Necroptosis and Apoptosis of Lung Epithelial Cells

Lingjun Dong, Fuxiang Liang, Zhiling Lou et al. · Cells · 2022 · 39 citations · Full text

Veterinary Medicine, Cell Biology, Pathobiology +14

Cangrelor alleviates bleomycin-induced pulmonary fibrosis by inhibiting platelet activation in mice

Tianwei Zhan, Tao-Feng Wei, Lingjun Dong et al. · Molecular Immunology · 2020 · 26 citations

Veterinary Medicine, Pharmacology, Pharmacotherapy +13

Sinomenine attenuates pulmonary fibrosis by downregulating TGF-β1/Smad3, PI3K/Akt and NF-κB signaling pathways

Fuqiang Yao, Minghao Xu, Lingjun Dong et al. · BMC Pulmonary Medicine · 2024 · 26 citations · Full text

Medicine, Pathobiology, Pharmacology +16

Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55

Linhai Fu, Zhupeng Li, Yuanlin Wu et al. · Biochemical Genetics · 2023 · 18 citations

Life Sciences, Cancer Biology, Oncology +15

1–5 of 7